 | What Is The Ownership Structure Like For BeyondSpring Inc. (NASDAQ:BYSI)? - Nasdaq nasdaq.com - April 9 at 7:51 PM |
 | BeyondSpring downgraded at H.C. Wainwright despite a potential launch of Plinabulin - Seeking Alpha seekingalpha.com - April 5 at 5:52 PM |
 | Focus on equipment makers as Citi unveils positive catalyst watch; Invitae upgraded on Softbank investment and more in today’s analyst action - Seeking Alpha seekingalpha.com - April 5 at 12:43 PM |
 | HC Wainwright Downgrades BeyondSpring (NASDAQ:BYSI) to Neutral americanbankingnews.com - April 5 at 8:40 AM |
 | BeyondSpring (NASDAQ:BYSI) Rating Lowered to Neutral at HC Wainwright americanbankingnews.com - April 5 at 8:02 AM |
 | A Peek Into The Markets: US Stock Futures Gain After Upbeat Jobs Data - Benzinga benzinga.com - April 5 at 7:43 AM |
 | -$0.95 EPS Expected for BeyondSpring Inc. (NASDAQ:BYSI) This Quarter americanbankingnews.com - April 4 at 10:18 PM |
 | BeyondSpring files plinabulin + G-CSF application in U.S. and China - Seeking Alpha seekingalpha.com - April 1 at 8:10 PM |
 | BeyondSpring Files US-China Application For Plinabulin G-CSF Treatment In Chemo-Induced Neutropenia - Yahoo Finance finance.yahoo.com - April 1 at 8:10 PM |
 | BeyondSpring Files US-China Application For Plinabulin G-CSF Treatment In Chemo-Induced Neutropenia finance.yahoo.com - April 1 at 3:10 PM |
|
 | Health Care Sector Update for 04/01/2021: SNOA, BYSI, CTIC, IYH, VHT, IBB - Nasdaq nasdaq.com - April 1 at 10:09 AM |
 | BeyondSpring Announces Submission of New Drug Application to U.S. FDA and China NMPA for Plinabulin and G-CSF Combination for the Prevention of Chemotherapy-Induced Neutropenia (CIN) - GlobeNewswire globenewswire.com - April 1 at 12:07 AM |
 | BeyondSpring Announces Submission of New Drug Application to U.S. FDA and China NMPA for Plinabulin and G-CSF Combination for the Prevention of Chemotherapy-Induced Neutropenia (CIN) finance.yahoo.com - April 1 at 12:07 AM |
 | Reviewing BeyondSpring (NASDAQ:BYSI) and Galectin Therapeutics (NASDAQ:GALT) americanbankingnews.com - March 26 at 12:36 AM |
 | Sizing Up A Bet In BeyondSpring - Seeking Alpha seekingalpha.com - March 25 at 8:07 PM |
 | Is BeyondSpring Inc.'s (NASDAQ:BYSI) Shareholder Ownership Skewed Towards Insiders? - Yahoo Finance finance.yahoo.com - March 21 at 2:54 PM |
 | Is BeyondSpring Inc.'s (NASDAQ:BYSI) Shareholder Ownership Skewed Towards Insiders? finance.yahoo.com - March 21 at 9:41 AM |
 | BeyondSpring Hosting Key Opinion Leader Webinar on Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia - GlobeNewswire globenewswire.com - March 11 at 7:50 PM |
 | BeyondSpring Hosting Key Opinion Leader Webinar on Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia finance.yahoo.com - March 11 at 7:50 PM |
 | 5 Top Stock Gainers for Wednesday: Bilibili, DermTech - TheStreet thestreet.com - December 30 at 2:57 PM |
 | Why Is It Moving? Analyzing The Upward Movement in BeyondSpring's Stock Today - Benzinga benzinga.com - December 29 at 1:59 PM |
 | UPDATE -- BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021 - Yahoo Finance finance.yahoo.com - December 29 at 1:59 PM |
 | UPDATE -- BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021 finance.yahoo.com - December 29 at 1:59 PM |
 | BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021 - Yahoo Finance finance.yahoo.com - December 29 at 8:59 AM |
 | BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021 finance.yahoo.com - December 29 at 8:59 AM |
 | BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors - GlobeNewswire globenewswire.com - December 17 at 9:33 AM |
|
 | BeyondSpring: Would Be A Great Buy Except For The Perennial Need For Cash And Ensuing Dilution - Seeking Alpha seekingalpha.com - December 15 at 9:45 AM |
 | BeyondSpring (BYSI) Reports New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results - StreetInsider.com streetinsider.com - December 10 at 11:14 PM |
 | BeyondSpring Announces New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results at the 2020 San Antonio Breast Cancer Symposium - GlobeNewswire globenewswire.com - December 10 at 6:13 PM |
 | BeyondSpring Announces New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results at the 2020 San Antonio Breast Cancer Symposium finance.yahoo.com - December 10 at 6:13 PM |
 | Do Hedge Funds Love BeyondSpring, Inc. (BYSI)? - Yahoo Finance finance.yahoo.com - November 29 at 5:51 PM |
 | Do Hedge Funds Love BeyondSpring, Inc. (BYSI)? finance.yahoo.com - November 29 at 5:51 PM |
 | BeyondSpring to Participate in Upcoming Evercore ISI 2020 Conference finance.yahoo.com - November 23 at 8:54 PM |
 | BeyondSpring slides 9% on public offering pricing at $10.0/share seekingalpha.com - November 19 at 12:50 PM |
 | BeyondSpring under pressure on shares offering seekingalpha.com - November 17 at 6:40 PM |
 | BeyondSpring Announces Third Quarter 2020 Financial Results and Provides Business Updates finance.yahoo.com - November 17 at 8:39 AM |
 | BeyondSpring's plinabulin combo meets primary endpoint in neutropenia trial seekingalpha.com - November 16 at 9:33 AM |
 | BeyondSpring Announces Positive Topline Results from its PROTECTIVE-2 Phase 3 Registrational Trial of Plinabulin in Combination with Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia finance.yahoo.com - November 16 at 9:33 AM |
 | BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference finance.yahoo.com - November 13 at 5:55 PM |
 | Seed Therapeutics, Eli Lilly in pact for protein degradation-based therapies seekingalpha.com - November 13 at 7:50 AM |
 | BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly finance.yahoo.com - November 13 at 7:50 AM |
 | Seed Therapeutics Launches Protein Degradation Research Platform and Appoints Edward Dongheng Liu as Chief Financial Officer markets.businessinsider.com - October 14 at 7:54 AM |
 | BeyondSpring Forms Partnership Advisory Committee Comprised of Industry Veterans markets.businessinsider.com - October 12 at 9:15 AM |
 | JAMA Oncology Highlights Plinabulin's Efficacy in Preventing Chemotherapy-Induced Neutropenia as a Monotherapy finance.yahoo.com - October 7 at 10:44 PM |
 | JAMA Oncology Highlights Plinabulin's Efficacy in Preventing Chemotherapy-Induced Neutropenia as a Monotherapy markets.businessinsider.com - September 29 at 12:43 PM |
 | BeyondSpring's manuscript on Plinabulin published in JAMA Oncology seekingalpha.com - September 29 at 12:43 PM |
 | Akero Continues Efruxifermin Trial, And Other News: The Good, Bad And Ugly Of Biopharma seekingalpha.com - September 29 at 7:42 AM |
 | BeyondSpring's Plinabulin at par with Amgen's pegfilgrastim seekingalpha.com - September 24 at 11:49 PM |
 | Additional data show BeyondSpring's plinabulin at par with Amgen's pegfilgrastim seekingalpha.com - September 24 at 1:48 PM |
 | BeyondSpring's Plinabulin effective in preventing life-threatening chemo-induced neutropenia seekingalpha.com - September 24 at 1:48 PM |